Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Related Articles by Review for PubMed (Select 22981850)

1.

Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16-17 November 2011.

Hughes B, Hayden F, Perikov Y, Hombach J, Tam JS.

Vaccine. 2012 Oct 19;30(47):6612-22. doi: 10.1016/j.vaccine.2012.08.073. Epub 2012 Sep 11.

PMID:
22981850
2.

Prospects for controlling future pandemics of influenza.

Robertson JS, Inglis SC.

Virus Res. 2011 Dec;162(1-2):39-46. doi: 10.1016/j.virusres.2011.09.024. Epub 2011 Sep 22. Review.

PMID:
21963676
3.

Trends in development of the influenza vaccine with broader cross-protection.

Stropkovská A, Janulíková J, Varecková E.

Acta Virol. 2010;54(1):7-19. Review.

PMID:
20201609
4.

Inactivated influenza vaccines: recent progress and implications for the elderly.

Parodi V, de Florentiis D, Martini M, Ansaldi F.

Drugs Aging. 2011 Feb 1;28(2):93-106. doi: 10.2165/11586770-000000000-00000. Review.

PMID:
21275435
5.

Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvant.

Ainai A, Tashiro M, Hasegawa H.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:174-82. Epub 2011 Jan 1. Review.

6.

Influenza vaccines: new developments.

Rimmelzwaan GF, Osterhaust AD.

Curr Opin Pharmacol. 2001 Oct;1(5):491-6. Review.

PMID:
11764775
7.

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.

van Riet E, Ainai A, Suzuki T, Hasegawa H.

Vaccine. 2012 Aug 31;30(40):5893-900. doi: 10.1016/j.vaccine.2012.04.109. Epub 2012 Jul 24. Review.

PMID:
22835738
8.

Pandemic preparedness: toward a universal influenza vaccine.

Roose K, Fiers W, Saelens X.

Drug News Perspect. 2009 Mar;22(2):80-92. doi: 10.1358/dnp.2009.22.2.1334451. Review.

PMID:
19330167
9.

Selection of influenza vaccine strains and developing pandemic vaccines.

Wood JM.

Vaccine. 2002 Dec 20;20 Suppl 5:B40-4. Review.

PMID:
12477418
10.

Influenza vaccines: the good, the bad, and the eggs.

Schultz-Cherry S, Jones JC.

Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Review.

PMID:
20951870
12.
13.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
14.

Improvement of inactivated influenza virus vaccines.

Couch RB, Keitel WA, Cate TR.

J Infect Dis. 1997 Aug;176 Suppl 1:S38-44. Review.

15.

Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries.

Monto AS, Black S, Plotkin SA, Orenstein WA.

Vaccine. 2011 Sep 2;29(38):6427-31. doi: 10.1016/j.vaccine.2011.06.113. Epub 2011 Jul 16. Review.

PMID:
21763381
16.

Influenza vaccines: what do we want and how can we get it?

Geeraedts F, Huckriede A.

Adv Exp Med Biol. 2011;780:161-74. doi: 10.1007/978-1-4419-5632-3_13. Review.

PMID:
21842372
17.

Immunity to influenza: the challenges of protecting an aging population.

Katz JM, Plowden J, Renshaw-Hoelscher M, Lu X, Tumpey TM, Sambhara S.

Immunol Res. 2004;29(1-3):113-24. Review.

PMID:
15181275
18.

New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.

Steel J.

BioDrugs. 2011 Oct 1;25(5):285-98. doi: 10.2165/11593870-000000000-00000. Review.

PMID:
21942913
19.

Emerging vaccines for influenza.

Tosh PK, Poland GA.

Expert Opin Emerg Drugs. 2008 Mar;13(1):21-40. doi: 10.1517/14728214.13.1.21 . Review.

PMID:
18321146
20.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk